Knowledge Center

15 October 2025
Cut Timelines and Costs in Late-Phase Oncology: Why Asia Should Be Your Next Trial Destination
Globally, cancer diagnoses are projected to reach 35.3 million new cases per year with death rates rising to 18.5 million by 2050.²

15 October 2025
Unlocking the Potential of FDA Expedited Approval and Voucher Programs: An Avance Clinical Partnership Approach
Our integrated approach combines deep regulatory expertise with world-class operational resources to guide Sponsors through every aspect of these complex programs, from initial eligibility assessment to managing post-approval commitments.

23 September 2025
Accelerating Development Through Parallel Execution and Rigorous Quality Controls
In a recent video interview with Applied Clinical Trials, Ben Edwards, Chief Operating Officer, Avance Clinical, discussed common challenges in biotech, emphasizing the importance of addressing preclinical package gaps to avoid delays.

17 April 2025
Advancing Rare Disease Clinical Trials: A High-Touch, Patient-Centered Approach for Biotechs
Avance Clinical supports biotech companies by employing patient-centered trial designs, innovative statistical methodologies, personalized patient support, and expert regulatory guidance.

6 March 2025
Avance Clinical North America: Proven Expertise With Global Solutions For US Biotechs
The success of a biotech drug development program often depends on the relationship it forms with its Clinical Research Organization (CRO) partner.

17 January 2025
Ensure Seamless Clinical Trial Transition Across Global Markets
To enable access to life-saving therapeutics, drug sponsors continue to explore new strategies for executing their clinical trials as rapidly and efficiently as possible.

5 January 2025
Delivering High-Quality Trials With Expert Consultation And Management In Cancer Research
The rapidly evolving landscape of oncology clinical trials, driven by innovative technologies and deeper insights into cancer biology, presents unique challenges and opportunities for U.S. biotech companies.

20 December 2024
Navigating the Risks: Why Compassionate Use Should Not Replace Rigorous Clinical Trials
Recently, we have observed an increasing number of queries from clients exploring the potential of utilizing 'special access-like schemes' to obtain clinical data, as an alternative to conducting properly structured clinical trials, due to challenges in securing necessary funding.

4 December 2024
Accessing Unapproved Therapeutic Modalities in the USA and Australia
Both the United States and Australia have established regulatory frameworks to address these needs, governed by the U.S. Food and Drug Administration (FDA) and Australia’s Therapeutic Goods Administration (TGA), respectively.

19 November 2024
Demystifying Cell and Gene Therapy Studies in Australia and the Broader APAC Region
The global cell and gene therapy (CGT) industry continues to accelerate, thanks to its potential to generate life-changing treatments across a range of chronic indications, including cancers and rare diseases.

10 October 2024
How Avance Clinical’s In-house ClinicReady Service Supports Early-Stage Biotech Companies to Secure Funding
For early-stage biotech companies, securing funding is often a significant challenge due to the complex and costly nature of drug development. Avance Clinical, a leading contract research organization (CRO), offers tailored consultancy services to help biotech companies navigate the investment process to bring their innovations to market.

2 September 2024
The Asia Advantage: Why US Biotechs Should Look East for Clinical Trials
This article explores the compelling reasons behind the Asia Advantage and highlights how Avance Clinical's strategic expansion into the region supports biotechs in maximizing these benefits.
Proven industry
experience & expertise
800+
Studies in the past 10 years
500+
Experienced team members
33k+
Participants past 10 years
30
Years of CRO experience